Condensed Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Common stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2019	$ 63,387	$ 14	$ 176,776	$ (113,519)	$ 116
Beginning Balance, shares at Dec. 31, 2019		14,488,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(3,555)			(3,555)
Other comprehensive loss, net of tax	(819)				(819)
Issuance of restricted stock	1	$ 1
Issuance of restricted stock, shares		19,000
Repurchase of common stock and retirement of related treasury shares	(48)		(48)
Repurchase of common stock and retirement of related treasury shares, shares		(7,000)
Stock options exercised	18		18
Stock options exercised, shares		6,000
Stock-based compensation	999		999
Ending Balance at Mar. 31, 2020	59,983	$ 15	177,745	(117,074)	(703)
Ending Balance, shares at Mar. 31, 2020		14,506,000
Beginning Balance at Dec. 31, 2020	116,399	$ 15	190,568	(74,773)	589
Beginning Balance, shares at Dec. 31, 2020		15,476,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	8,838			8,838
Other comprehensive loss, net of tax	(711)				(711)
Issuance of restricted stock	113		113
Issuance of restricted stock, shares		26,000
Repurchase of common stock and retirement of related treasury shares	(215)		(215)
Repurchase of common stock and retirement of related treasury shares, shares		(6,000)
Stock options exercised	$ 912	$ 1	911
Stock options exercised, shares	158,544	159,000
Stock-based compensation	$ 1,786		1,786
Ending Balance at Mar. 31, 2021	$ 127,122	$ 16	$ 193,163	$ (65,935)	$ (122)
Ending Balance, shares at Mar. 31, 2021		15,655,000